A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Completed · Phase 3

Conditions studied: Parkinson's Disease Psychosis

In brief

To assess the long-term safety and tolerability of ACP-103 in subjects with Parkinson's disease psychosis.

Key facts

Study ID

NCT00550238

Run by

ACADIA Pharmaceuticals Inc.

People needed

459

Starts

2007-07-01

Expected to finish

2018-05-30

Last updated by the study team

2019-06-24

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has completed the treatment period of a previous blinded study of pimavanserin
• The subject is willing and able to provide consent
• Caregiver is willing and able to accompany the subject to all visits

You may not qualify if…

• Subject has current evidence of a serious and or unstable cardiovascular, respiratory, gastrointestinal, renal, hematologic or other medical disorder
• Subject is judged by the Investigator to be inappropriate for the study

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Berkeley, California, United States
• Study site — Carson, California, United States
• Study site — Fountain Valley, California, United States
• Study site — Fresno, California, United States
• Study site — Irvine, California, United States
• Study site — La Habra, California, United States
• Study site — La Jolla, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Loma Linda, California, United States
• Study site — Oxnard, California, United States
• Study site — Pasadena, California, United States
• Study site — Reseda, California, United States
• Study site — Sunnyvale, California, United States
• Study site — Ventura, California, United States
• Study site — Englewood, Colorado, United States
• Study site — Danbury, Connecticut, United States
• Study site — Fairfield, Connecticut, United States
• Study site — Farmington, Connecticut, United States
• Study site — Boca Raton, Florida, United States
• Study site — Bradenton, Florida, United States
• Study site — Deerfield Beach, Florida, United States
• Study site — Gainesville, Florida, United States
• Study site — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.